KEITH A BAGGERLY to Leukemia, Myeloid
This is a "connection" page, showing publications KEITH A BAGGERLY has written about Leukemia, Myeloid.
Connection Strength
0.084
-
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia. Clin Cancer Res. 2014 Apr 15; 20(8):2226-35.
Score: 0.084